Bo Feng

机构：University of Nottingham Ningbo China, Chinese Academy of Sciences, Shanghai Advanced Research Institute, Advanced Coatings (Belgium) · ORCID：0000-0002-1764-8028

发表论文 57 篇 · 总被引 874 次 · h-index 17

代表论文

• The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer (2025 · Nature Immunology · 被引 67)
• Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer (2025 · JAMA · 被引 35)
• Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial (2025 · BMJ · 被引 25)
• Discovery and characterization of novel potent non-covalent small molecule inhibitors targeting papain-like protease from SARS-CoV-2 (2024 · Acta Pharmaceutica Sinica B · 被引 17)
• A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses (2025 · Journal of Nanobiotechnology · 被引 12)
• Hematoporphyrin-Modified Dendrimers Combined Immunoadjuvants for Enhanced Photoimmunotherapy of Colorectal Cancer (2025 · ACS Applied Materials & Interfaces · 被引 9)